|
|
|
Volumn 91, Issue 5, 2013, Pages 59-64
|
|
[Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE;
GAMMA GLUTAMYLTRANSFERASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIDINE DERIVATIVE;
AGED;
ARTICLE;
BLOOD;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG COMBINATION;
DRUG EFFECT;
FATTY LIVER;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONALCOHOLIC FATTY LIVER;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
CORONARY DISEASE;
DIABETES MELLITUS, TYPE 2;
DRUG EFFECTS;
AGED;
CORONARY DISEASE;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
FATTY LIVER;
FEMALE;
GAMMA-GLUTAMYLTRANSFERASE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
PYRIDINES;
TREATMENT OUTCOME;
NON-ALCOHOLIC FATTY LIVER DISEASE;
|
|
EID: 84893422390
PISSN: 00232149
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
